Oxler Private Wealth’s Editas Medicine EDIT Stock Holding History

Oxler Private Wealth’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-50	Closed	-$3K	–	149
2020 Q4	$3K	Buy	+50	New	+$2.05K	﹤0.01%	216

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Oxler Private Wealth's EDIT Position: Q1 2021 in Review

Oxler Private Wealth sold out of Editas Medicine (EDIT) in Q1 2021, closing a stake of 50 shares — an estimated $3K sold.

Oxler Private Wealth first reported a position in EDIT in Q4 2020 and held it in 1 quarter. The position peaked at $3K in Q4 2020. 312 funds tracked by Wall St. Rank hold EDIT as of Q1 2021.

Oxler Private Wealth reported no remaining Editas Medicine position as of Q1 2021 after selling out during the quarter.
Oxler Private Wealth sold 50 Editas Medicine shares in Q1 2021, an estimated $3K.
Oxler Private Wealth first reported a position in Editas Medicine in Q4 2020 and held it in 1 quarter.
Oxler Private Wealth's Editas Medicine position peaked at $3K in Q4 2020.
312 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2021.

Based on Oxler Private Wealth's 13F filing for Q1 2021, filed 3 May 2021.